HomeVRAX • NASDAQ
add
Virax Biolabs Group Ltd
Previous close
$0.92
Day range
$0.87 - $0.96
Year range
$0.74 - $9.00
Market cap
4.00M USD
Avg Volume
68.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 689.00 | -98.28% |
Operating expense | 1.62M | -5.89% |
Net income | -1.65M | 13.57% |
Net profit margin | -239.83K | -4,912.44% |
Earnings per share | — | — |
EBITDA | -1.57M | 6.28% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.32M | 17.91% |
Total assets | 6.43M | 17.19% |
Total liabilities | 964.75K | 179.48% |
Total equity | 5.46M | — |
Shares outstanding | 4.34M | — |
Price to book | 0.70 | — |
Return on assets | -63.87% | — |
Return on capital | -66.46% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.65M | 13.57% |
Cash from operations | -1.32M | 0.31% |
Cash from investing | -177.95K | 22.00% |
Cash from financing | -28.10K | -103.53% |
Net change in cash | -1.53M | -101.30% |
Free cash flow | -826.13K | -19.22% |
About
Founded
2013
Website
Employees
19
